You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelodysplasia Syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Refine and Assess Readability of Patient, Carer, and Clinician

Completed
  • Myelodysplastic Syndrome (MDS)
  • Carer Treatment Preference Myelodysplasia Questionnaire
  • +2 more
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
Apr 4, 2023

Acute Myeloid Leukemia, MDS Trial in China (Fludarabine, busulfan and melphalan, Fludarabine and Busulfan)

Active, not recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndromes
  • Fludarabine, busulfan and melphalan
  • Fludarabine and Busulfan
  • Fuzhou, Fujian, China
  • +8 more
Aug 14, 2023

Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myeloblasts 10 Percent or More of Bone Marrow Nucleated Cells Trial in

Recruiting
  • Acute Myeloid Leukemia
  • +7 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
May 16, 2022

MDS, Acute Myeloid Leukemia With Myelodysplasia Related Disease and < 30% Blasts, Mixed Myelodysplastic/Myeloproliferative

Recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Stockholm, Sweden
    Department of Hematology, Karolinska University Hospital
Mar 27, 2023

Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome Trial in Australia, Netherlands,

Recruiting
  • Acute Lymphocytic Leukaemia; Acute Myeloid Leukaemia Refractory; Myelodysplastic Syndrome
  • Duarte, California
  • +12 more
Jan 4, 2023

Previously Treated Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia With

Active, not recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +7 more
  • Duarte, California
  • +10 more
Jul 2, 2022

Acute Myeloid Leukemia, Myelodysplasia Trial in Roma (Haplo SCT with NK cells, Haplo SCT)

Recruiting
  • Acute Myeloid Leukemia
  • Myelodysplasia
  • Haplo SCT with NK cells
  • Haplo SCT
  • Roma, RM, Italy
    Fondazione Policlinico Universitario A. Gemelli IRCCS
Oct 14, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Myelodysplasia-Related

Active, not recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +2 more
  • Tucson, Arizona
  • +2 more
Aug 5, 2022

Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial

Active, not recruiting
  • Acute Leukemia
  • +14 more
  • Duarte, California
    City of Hope Medical Center
Nov 18, 2022

Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States

Completed
Has Results
  • Acute Myeloid Leukemia
  • +19 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Lewes, Delaware
  • +16 more
Aug 3, 2022

Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States

Completed
Has Results
  • Acute Myelogenous Leukemia
  • +4 more
  • Single Umbilical Cord Blood Unit Transplant
  • +6 more
  • Birmingham, Alabama
  • +37 more
Oct 13, 2021

Acute Myeloid Leukemia in Remission, Lymphoma in Remission, Non-progressive Myeloproliferative Syndrome Trial in Belgium,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +5 more
  • Ex vivo capacities of CD4neg INkT expansion of the peripheral blood donor with the Predictor test
  • Antwerpen, Belgium
  • +21 more
Sep 27, 2021

Myelodysplastic Syndrome (MDS) Trial run by the NHLBI (ON 01910 Na)

Completed
  • Myelodysplastic Syndrome (MDS)
  • ON 01910 Na
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 14, 2019

MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

Not yet recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • Subcutaneous azacitidine
  • Oral decitabine/cedazuridine
  • Newcastle, New South Wales, Australia
    Calvary Mater Newcastle
May 29, 2023

Myelodysplastic Syndrome Trial in Japan (SyB C-1101 and Azacytidine)

Withdrawn
  • Myelodysplastic Syndrome
  • SyB C-1101 and Azacytidine
  • Nagoya, Aichi, Japan
  • +3 more
Nov 14, 2022

Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Indianapolis (Fludarabine + Total Marrow

Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Fludarabine + Total Marrow Irradiation
  • Indianapolis, Indiana
    Indiana University Melvin and Bren Simon Comprehensive Cancer Ce
Jun 1, 2022

High Risk Hematological Malignancy, Cord Blood Transplant Trial in Seattle (ECT-001-CB (UM171-Expanded Cord Blood Transplant))

Recruiting
  • High Risk Hematological Malignancy
  • Cord Blood Transplant
  • ECT-001-CB (UM171-Expanded Cord Blood Transplant)
  • Seattle, Washington
    Fred Hutchinson / University of Washington Cancer Consortium
Jan 12, 2022

Acute Myelogenous Leukemia (AML) Due to Therapy, Acute Myeloid Leukemia With Myelodysplasia-Related Changes Trial in La Jolla,

Recruiting
  • Acute Myelogenous Leukemia (AML) Due to Therapy
  • Acute Myeloid Leukemia With Myelodysplasia-Related Changes
  • Orange, California
  • +2 more
Nov 30, 2022

High Risk Hematologic Malignancy, Cord Blood Transplant Trial in Montréal (Transplant with an expanded ECT-001 cord blood)

Recruiting
  • High Risk Hematologic Malignancy
  • Cord Blood Transplant
  • Transplant with an expanded ECT-001 cord blood
  • Montréal, Quebec, Canada
    CIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemo
Aug 2, 2021

Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, High Risk

Recruiting
  • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
  • +5 more
  • Gemtuzumab Ozogamicin
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

MDS Trial in Worldwide (Oral Azacitidine, Placebo for Oral Azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • Oral Azacitidine
  • Placebo for Oral Azacitidine
  • Buenos Aires, Argentina
  • +1 more
Aug 1, 2022

MDS, Transfusion-dependent Anemia Trial in France (Transfusion)

Recruiting
  • Myelodysplastic Syndromes
  • Transfusion-dependent Anemia
  • Transfusion
  • Abbeville, France
  • +18 more
Apr 4, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Biospecimen Collection
  • +3 more
  • Baltimore, Maryland
  • +2 more
Jan 19, 2023

Moxetumomab Pasudotox-tdfk (LUMOXITI)

Recruiting
  • Hairy Cell Leukemia
    • Pueblo, Colorado
    • +1 more
    Aug 17, 2022